2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$8.57-$0.005 (-0.06%)
Price as of Jun 23, 2026 1:34 PM EDT- $2.0BMarket Cap
- -52.04%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$8.57-$0.005 (-0.06%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 510.2M +19.63% | 426.5M +65.15% | 258.2M +67.59% | 154.1M +90.36% | |
Cost of Revenue | 217.4M +5.08% | 206.9M +22.23% | 169.3M +42.47% | 118.8M +48.95% | |
Gross Profit | 292.8M +33.35% | 219.6M +146.85% | 88.9M +152.21% | 35.3M +2,905.68% | |
Sales and Marketing Expense | 91.6M +23.55% | 74.1M +25.59% | 59.0M +12.51% | 52.5M +22.29% | |
Research and Development Expense | -4.8M +162.66% | -1.8M -45.06% | -3.3M -8.68% | -3.6M -0.89% | |
Depreciation and Amortization Expense | 8.1M +0.63% | 8.0M -3.44% | 8.3M +17.13% | 7.1M +29.44% | |
Total Operating Expenses | 101.3M +25.76% | 80.6M +19.70% | 67.3M -9.81% | 74.6M +25.33% | |
Operating Profit | 191.4M +37.75% | 139.0M +542.49% | 21.6M +154.95% | -39.4M -32.56% | |
Interest Income | 1.9M -10.78% | 2.1M +29.68% | 1.6M +3,506.72% | 44,833 +29.83% | |
Interest Expense | N/A N/A | N/A N/A | -25.0M +29.81% | -19.3M +47.66% | |
Interest Income and Expense and Net | 1.9M -10.78% | 2.1M +108.96% | -23.4M +21.71% | -19.2M +47.70% | |
Total Nonoperating Income and Expense | -8.8M -33.78% | -13.3M -73.39% | -49.9M +87.92% | -26.5M +99.93% | |
Income before Taxes | 182.7M +45.29% | 125.7M +481.15% | 21.6M +154.95% | -39.4M -32.56% | |
Income Taxes | 35.7M +149.65% | -72.0M N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 146.9M -25.67% | 197.7M +800.00% | -28.2M -57.15% | -65.9M -8.02% | |
Net Income from Continuing Operations Applicable to Common | 182.7M +45.29% | 125.7M +545.18% | -28.2M -57.15% | -65.9M -8.02% | |
Basic EPS and Net Income | 0.62 -27.06% | 0.85 +753.85% | -0.13 -60.61% | -0.33 -35.29% | |
Diluted EPS and Net Income | 0.60 -25.93% | 0.81 +723.08% | -0.13 -60.61% | -0.33 -35.29% | |
Basic Weighted Average Shares | 238.3M +2.24% | 233.1M +4.07% | 224.0M +13.19% | 197.9M +41.77% | |
Diluted Weighted Average Shares | 244.9M +0.64% | 243.3M +8.65% | 224.0M +13.19% | 197.9M +41.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 87.6M -15.04% | 103.1M +100.86% | 51.4M -40.65% | 86.5M +69.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 87.6M -15.04% | 103.1M +100.86% | 51.4M -40.65% | 86.5M +69.35% | |
Total Current Assets | 466.5M +40.77% | 331.4M +28.95% | 257.0M -4.95% | 270.4M +29.55% | |
Accumulated Depreciation | 38.3M +14.29% | 33.6M +25.49% | 26.7M +37.28% | 19.5M +46.75% | |
Property and Plant and Equipment and Net | 65.1M +18.92% | 54.7M +1.62% | 53.8M -7.60% | 58.3M +14.38% | |
Total Long-Term Assets | 65.1M +18.92% | 54.7M +1.62% | 53.8M -7.60% | 58.3M +14.38% | |
Total Assets | 624.2M +27.74% | 488.7M +48.45% | 329.2M -5.53% | 348.5M +26.14% | |
Income Taxes Payable | 8.6M +147.52% | 3.5M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 69.5M +25.20% | 55.5M +11.52% | 49.8M +26.84% | 39.3M +29.26% | |
Total Long-Term Debt | 69.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 360,000 -14.08% | 419,000 +19.56% | 350,454 -11.80% | |
Total Liabilities | 146.9M +5.20% | 139.7M -28.00% | 194.0M -1.28% | 196.5M +45.46% | |
Retained Earnings | -161.7M -47.61% | -308.6M -39.05% | -506.3M +5.91% | -478.0M +15.99% | |
Total Stockholders Equity | 477.3M +36.76% | 349.0M +158.14% | 135.2M -11.03% | 152.0M +7.65% | |
Total Shares Outstanding | 237.9M +0.53% | 236.6M +4.67% | 226.1M +1.91% | 221.8M +13.28% | |
Cash Flow | |||||
Cash from Operating Activities | 50.4M -57.53% | 118.7M +1,248.55% | 8.8M +114.79% | -59.5M -47.04% | |
Capital Expenditures | 22.6M +174.43% | 8.2M +72.42% | 4.8M -65.70% | 13.9M +2.96% | |
Cash from Investing Activities | -21.9M +155.29% | -8.6M +72.15% | -5.0M -64.19% | -13.9M +2.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -44.0M -24.49% | -58.3M +49.53% | -39.0M -135.82% | 108.9M -10.08% | |
Financials Ratio | |||||
Gross Margin | 57.39% +11.46% | 51.48% +49.47% | 34.44% +50.50% | 22.89% +1,479.00% | |
Operating Margin | 37.53% +15.14% | 32.59% +289.02% | 8.38% +132.79% | -25.55% -64.57% | |
Return on Assets | 26.40% -45.38% | 48.34% +679.99% | -8.33% -60.50% | -21.10% -28.75% | |
Return on Equity | 35.56% -56.44% | 81.65% +515.15% | -19.67% -56.26% | -44.96% -28.01% | |
Revenue Growth | 19.63% -69.87% | 65.15% -3.60% | 67.59% -25.20% | 90.36% -1.48% | |
Current Ratio | 6.71 +12.43% | 5.97 +15.63% | 5.16 -25.06% | 6.89 +0.22% | |
Cash Ratio | 1.26 -32.15% | 1.86 +80.13% | 1.03 -53.21% | 2.20 +31.01% | |
Debt-to-Equity Ratio | 0.15 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.12 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow